ECT Anesthesia: Balancing Seizures and Hemodynamics

If you’re like me, the first time you covered ECT you were surprised by how physiologically dramatic a "brief" procedure can be. T-waves going inverted, heart rate spiking to 150, then crashing to 40 with a 5-second sinus pause, all in the space of 60 seconds — in a room with no surgeon and no backup. ECT is the unusual case where the therapeutic goal requires a seizure, and your job is to make that seizure happen safely without your anesthetic drugs killing the treatment.

On the anesthesiology oral boards, ECT tests your knowledge of a niche but specific set of drug interactions and autonomic physiology. The examiner wants to know: what agent do you use, why does it matter, and how do you handle the cardiovascular swings?

The Core Logic

ECT works by inducing a generalized tonic-clonic seizure via a brief electrical stimulus. The therapeutic effect is proportional to seizure duration — a generalized motor seizure of at least 25-30 seconds is the target. Anesthetic agents suppress seizure activity in a dose-dependent fashion. Your induction agent choice directly determines whether the patient gets a therapeutic seizure or a brief, inadequate jerk.

The autonomic response to ECT is biphasic. The electrical stimulus first triggers a vagal surge: bradycardia, sometimes asystole, and increased secretions. This lasts 5-10 seconds. Then the sympathetic response dominates: tachycardia, hypertension, and increased myocardial oxygen demand. This lasts until the seizure terminates. Your job is to anticipate and manage both phases.

How the Examiner Tests This

Standard scenario: a 58-year-old with treatment-resistant depression and a history of hypertension, scheduled for ECT. "What induction agent will you use?" This is the core question. "Why not propofol?" Propofol raises the seizure threshold and shortens seizure duration more than other agents — it’s your worst choice if therapeutic seizure is the goal. "What do you do if the heart rate drops to 35 after the stimulus?" Have atropine ready — this is the parasympathetic surge, and it’s expected.

The hardest probe: "The psychiatrist says the seizure only lasted 15 seconds — what happened and what do you do next?" This prompts a discussion of seizure adequacy, dose adjustments, and whether to use caffeine (which lowers seizure threshold) or simply decrease the propofol/methohexital dose at the next treatment.

The Board Trap

The propofol trap: it’s the most common induction agent in anesthesia practice, and the reflex is to use it everywhere. In ECT, propofol’s anticonvulsant properties directly undermine the treatment. If you use it, you should be prepared to defend why — specifically that you’re using the lowest possible dose (0.75 mg/kg or less) to minimize seizure suppression.

The second trap: treating the initial bradycardia aggressively before it’s needed. Routine pretreatment with atropine for every patient every session is outdated practice. The bradycardia is self-limited (it resolves as the sympathetic surge kicks in). Reserve atropine or glycopyrrolate for patients with known cardiac conduction disease or for sessions where the bradycardia is symptomatic or prolonged.

Lead-In Phrases

• "I will use methohexital 0.75-1.0 mg/kg as my induction agent — it has the least anticonvulsant activity of the available agents and provides the most reliable therapeutic seizure."
• "I will use succinylcholine 0.5-1.0 mg/kg for paralysis — I want a brief, complete motor block to protect against fractures during the tonic-clonic phase, with a short enough duration to allow rapid emergence."
• "I will anticipate a biphasic autonomic response: initial parasympathetic surge with bradycardia at the moment of stimulation, followed by a sustained sympathetic surge with hypertension and tachycardia during the seizure."
• "I will have esmolol or labetalol immediately available to manage the post-ictal hypertensive surge — particularly important for this patient’s known history of hypertension."
• "If the seizure duration is inadequate, I will discuss with the psychiatrist adjusting the stimulus parameters before changing the anesthetic — the anesthetic adjustment is a secondary intervention, not the first step."

FAQs

What if the patient has a pacemaker?

ECT can theoretically interfere with pacemaker function through the electrical stimulus or through the sympathetic surge triggering atrial arrhythmias. I would consult cardiology before the first ECT session, determine whether the device is MRI-conditional, and discuss programming the device to an asynchronous mode if the patient is pacemaker-dependent. Have external pacing pads available.

What is the concern with ketamine for ECT?

Ketamine has been used as an ECT induction agent because it theoretically lowers the seizure threshold and has its own antidepressant properties. However, its sympathomimetic effects significantly worsen the already intense post-ictal hypertensive surge. On the boards, ketamine is a defensible alternative if you acknowledge this limitation and have a hemodynamic management plan ready.

How do I manage a prolonged seizure (status epilepticus) during ECT?

If the seizure extends beyond 2 minutes, it needs to be terminated. I will use additional propofol or midazolam to break the seizure — at this point, their anticonvulsant properties become the therapeutic goal, not the liability. A prolonged generalized seizure causes hyperthermia, hypoxia, and rhabdomyolysis if not treated. The treatment paradox: the same drugs I avoided to facilitate the seizure are now what I need to stop it.

ECT anesthesia is a niche topic with very specific right answers. Methohexital, succinylcholine, biphasic autonomic sequence, seizure duration as your therapeutic endpoint — practice these out loud in Boards Bot until they’re automatic, because the ECT scenario often arrives as a quick 10-minute challenge in the middle of a longer session.